Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$29,675,183
New position
Shares Held
197,795
first reported quarter
Ownership
0.147%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#94
of 594 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026TREMBLANT CAPITAL GROUP holds $82,348,250 across 3 Diagnostics & Research names. GH ranks #2 (36.0% of the industry book) .
All Filings in GH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,675,183 | 197,795 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||